Hear from the report authors as they share key findings on global medicine use and rising spending, driven by innovative therapies and widening access. This report analyzes global trends and provides insights for stakeholders through 2029.
Watch our eminent panelists share their perspectives on the impact of the IRA on oncology drug development strategy, the implications for clinical development stakeholders, and approaches to mitigating unintended consequences for innovation at the IQVIA Institute’s Pre-ASCO Symposium 2025.
Our most recent R&D Trends report indicates that the R&D industry was recapturing momentum in 2024.
Learn about spending and usage of medicines in the past year and outlook to the future, globally and across specific therapy areas and countries.
Discover trends in drug approvals and launches, pipeline activity, and data on clinical trial activity.
Examine the state of the U.S. health system, medicine usage, drug pricing, and costs for patients.
Explore research and development in oncology and the progress being made to improve representativeness of race and ethnicity in clinical trial populations.